Drug Information Association (DIA) 2016 Conference presentation by John Reites on June 26, 2016. Session entitled; "Digital Health Debate" including this presentation on the four strategies to influence digital health approaches in clinical research studies.

1. 1
Digital Health Debate
Four (4) Strategies to Influence Digital Health Approaches in
Clinical Research Studies
John Reites
Head of Digital Health Accelerator
Quintiles
@JohnReites @Quintiles

2. 2

3. 3

4. 4
Influence your
KEY stakeholders1

5. 5
The Early Adopters
Subscribe to a service that most people are aware of…
US Population 319M
8M
Numbers are approximate based on sources and rounded for ease of review

6. 6
The Slow Adopters
Subscribe to a service that most people would be surprised is available…
US Population
2M
Numbers are approximate based on sources and rounded for ease of review
319M

7. 7
Your KEY Stakeholders and
Influence Opportunity
Slow
Adopters
Early
Adopters

8. 8
Detail the SCALED
Business Case2

9. 9
Digital Health Accelerator
Lean Canvas Business Case <Project Name>
<start date>
<end date>
Customer/Quintiles
Challenge
Problem this project is
working to solve
Potential Solution
Key features planned
Metrics/KPIs
Key activities you
measure
Unique Value
Proposition
Single, clear,
compelling message
that states why this
innovation is different
and worth paying
attention for our
customer and/or
market
Unfair Advantage
Can’t be easily copied
or bought as a
differentiator
Channels
Path to customers
and/or market via
integration, sales,
process, etc.
Customer Segments
Target customers and
product users including
company divisions,
roles, etc.
Cost Structure
Anticipated management costs, distribution costs, hosting,
resources, vendors, etc.
Revenue Streams
Revenue model, lifetime value, projected gross margin, etc.
PRODUCT MARKET

10. 10

11. 11
PURPOSE
1
What is the key objective for using this digital health approach in
the study (i.e. what will we accomplish by integrating it into the
registry)?
USABILITY
2
What is the plan for integration of the approach in the operations of
the registry with the physician and patient?
3
Would a patient use the digital health approach and see direct
benefit/engagement?
4
Who will be providing patients with technical support should
something go wrong with the device itself?
DATA CAPTURE
5
Can the provenance of data captured be verified? Are you willing to
accept the risk that data may be from another person who is not
the patient?
6
Could the data collected be stored in one country or would it have
to be stored in multiple countries?
7
Are there any restrictions on where the data could be analyzed
(e.g., country restrictions)?
When determining which digital health approach or device will be utilized in a registry, it is important for the following criteria to be met as a baseline for
evaluation. This checklist is intended to serve as a guide in the decision making process and is not comprehensive of all study issues that should be evaluated
prior to the use of a digital health approach or device within a registry. If the study team involved is unable to answer the criteria question below or if the
response does not hold “significant” impact to the registry, careful consideration should be given to whether or not the approach/device is best suited for use.
Digital Health Approach Criteria Worksheet

12. 12
Integrate the OMNI-
CHANNEL Experience3

13. 13
A multichannel approach that seeks to provide the customer (i.e. the
patient, site, primary investigator) with a frictionless engagement
experience utilizing all available channels to their strengths including
desktop, mobile, app, SMS text, telephone, tele-health, internet of
things (IoT) device, on site, etc.
What is Omni-Channel?

14. 14
Digital Health Accelerator Case Studies
Internet of Things (IoT)
Remote Monitoring
Apple ResearchKit
and CareKit
mHealth
Augmented Reality / Virtual Reality
eConsent and Training
Wearables, Medical
Devices and Apps
BYOD Patient Use

15. 15
Action the ITERATIVE
Design Process4

16. 16

17. 17
Develop
Simulate Learn
Revise
Repeat

18. 18

19. 19
John Reites
Head of Digital Health Accelerator
Quintiles
@JohnReites @Quintiles
Join the conversation #DIA2016
Thank You

20. 20
The views and opinions expressed in the following PowerPoint slides
are those of the individual presenter and should not be attributed to
Drug Information Association, Inc. (“DIA”), its directors, officers,
employees, volunteers, members, chapters, councils, Communities or
affiliates, or any organization with which the presenter is employed or
affiliated.
These PowerPoint slides are the intellectual property of the individual
presenter and are protected under the copyright laws of the United
States of America and other countries. Used by permission. All rights
reserved. Drug Information Association, Drug Information Association
Inc., DIA and DIA logo are registered trademarks. All other trademarks
are the property of their respective owners.
Disclaimer